Start Date
November 30, 2015
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
AZD9977 immediate release (IR) oral suspension
120 mg (4.8 mL x 25 mg/mL) oral suspension, single dose
AZD9977 extended release (ER) capsules [fast]
120 mg (2 x 60mg capsules) single dose
AZD9977 extended release (ER) capsules [intermediate]
120 mg (2 x 60mg capsules) single dose
AZD9977 extended release (ER) capsules [slow]
120 mg (2 x 60mg capsules) single dose
Research Site, Harrow
Lead Sponsor
AstraZeneca
INDUSTRY